DNA X, Inc. SONM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 44.13M | 59.11M | 57.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 44.13M | 59.11M | 57.92M |
| Cost of Revenue | -- | -- | 14.40M | 29.81M | 26.20M |
| Gross Profit | -- | -- | 1.82M | 1.39M | 3.80M |
| SG&A Expenses | -- | -- | 5.41M | 16.61M | 16.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 5.41M | 59.11M | 56.31M |
| Operating Income | -- | -- | -5.41M | -27.91M | -26.31M |
| Income Before Tax | -- | -- | -7.96M | -29.15M | -26.88M |
| Income Tax Expenses | -- | -- | 90.00K | 37.00K | 64.00K |
| Earnings from Continuing Operations | -- | -- | -7.96 | -29.19 | -26.95 |
| Earnings from Discontinued Operations | -- | -- | -12.70M | -4.20M | -4.20M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -20.66M | -33.38M | -31.14M |
| EBIT | -- | -- | -5.41M | -27.91M | -26.31M |
| EBITDA | -- | -- | -1.11M | -25.09M | -23.52M |
| EPS Basic | -- | -- | -26.94 | -96.99 | -101.49 |
| Normalized Basic EPS | -- | -- | -5.61 | -55.60 | -58.19 |
| EPS Diluted | -- | -- | -26.94 | -97.06 | -101.55 |
| Normalized Diluted EPS | -- | -- | -5.61 | -55.60 | -58.19 |
| Average Basic Shares Outstanding | -- | -- | 2.56M | 2.11M | 1.39M |
| Average Diluted Shares Outstanding | -- | -- | 2.56M | 2.11M | 1.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |